| Description | The file includes a copy of Sir John Vane's itinerary, correspondence and information concerning the symposium, 'Exploring the roles of of new agents in the management of musculoskeletal pain, OA and RA', correspondence regarding the slides to be used by Sir John Vane during his keynote address, including rough outlines of a slide concerning a trial using celecoxib (400mg BID) and a further slide concerning Alzheimer's disease, and a copy of a press release entitled 'COX 2 inhibitors might be useful in cancer prevention', by Scott Gotlieb. |